ArticleIn vitro models2022
Evaluation of calcium phosphate-coated polycaprolactone/graphene oxide scaffold with macro- and microporous structure for bone tissue engineering.
Article in In vitro models, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to fabricate porous PCL/GO scaffolds by adding graphene oxide (GO) which is a hydrophilic material to improve cell affinity of PCL. Calcium phosphate (CaP) coating was performed to enhance the bioactivity of the composite scaffold. The phase separation methods and the salt leaching process were used to impart high porosity and pores of various sizes in the scaffolds. Methods: The scaffolds were characterized by scanning electron microscopy (SEM), energy-dispersive X-ray spectrometry (EDS), water contact angle test, swelling test, and mechanical tests. For in vitro evaluation, cell morphology and viability test, alkaline phosphatase (ALP) activity, and double-stranded DNA (dsDNA) quantification were performed using mouse bone marrow stem cells (mBMSCs). Results: All scaffolds had interconnected pore networks for transporting nutrients, oxygen, and waste products. GO addition and CaP coating improved hydrophilicity, swelling behavior, mechanical properties, and cell proliferation properties of the scaffolds by creating a biomimetic 3D microenvironment. The PCL/GO/CaP scaffold laden with mBMSCs had no clear cytotoxicity and further promoted osteogenic differentiation compared to the groups without GO or CaP. Conclusions: Our results suggest that the porous PCL/GO/CaP scaffold showed enhanced hydrophilicity and swelling behavior and exerted beneficial effects on cell proliferation and differentiation. This composite scaffold shows potential for clinical application in bone tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.